CA Patent

CA2604943A1 — Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

Assigned to Tolmar Inc · Expires 2006-10-26 · 20y expired

What this patent protects

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters , e.g., testosterone palmitate, are disclosed. Meth…

USPTO Abstract

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters , e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations a re also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2604943A1
Jurisdiction
CA
Classification
—
Expires
2006-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Tolmar Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.